Tom Schwarz

Chairman at

20Med Therapeutics BV

71 year

14 connections

Finance

Health Technology

Consumer Services

Profile

Tom Schwarz is the founder of LSP Management Group BV, Erasmus Medical Center (Private Equity), and Seed Fund Management BV.
LSP Management Group BV was founded in 1998, Erasmus Medical Center (Private Equity) was founded in 2007, and Seed Fund Management BV was founded in 2009.
Dr. Schwarz's current jobs include Chairman-Supervisory Board at 20Med Therapeutics BV, Director-Supervisory Board at Corgo NV, Member-Supervisory Board at Regenesance BV, and General Partner at Innovation Industries Management BV.
Dr. Schwarz's former jobs include Chairman at AIMM Therapeutics BV, Director at Micronit Microfluidics BV, and Partner at Twente Technology Fund Management BV.
Dr. Schwarz received an undergraduate degree from the University of Utrecht.

Tom Schwarz active positions

Companies	Position	Start
Corgo NV Corgo NV Miscellaneous Commercial ServicesCommercial Services Specializes in corporate consulting services	Director/Board Member	05/05/2009
Regenesance BV Regenesance BV Drugstore ChainsRetail Trade Develops drugs for the treatment of neurodegenerative and immune mediated disorders	Director/Board Member	01/02/2011
20Med Therapeutics BV 20Med Therapeutics BV BiotechnologyHealth Technology Operates as a biomedical company	Chairman	-
Innovation Industries Management BV Innovation Industries Management BV Investment ManagersFinance Innovation Industries Management invests in companies located in Netherlands. The firm targets companies operating in the fields of industrial tech, med-tech and agri-tech industries. It provides for early and growth stage capital requirements with an investment size up to EUR 150 million.	Private Equity Investor	01/01/2016

All active positions of Tom Schwarz

Former positions of Tom Schwarz

Companies	Position	End
Erasmus Medical Center (Private Equity) Erasmus Medical Center (Private Equity) Investment ManagersFinance The Erasmus Fund's investment objective is to provide capital to support biomedical entrepreneurial activity at the Erasmus MC as well as in the Rotterdam area. The fund's investment strategy targets pre-seed, seed and early-stage firms and university spin-outs that are developing commercially promising technologies and products. They focus on the life science sector, including biotechnology, biomedical, pharmaceuticals, information technology and other high technology opportunities. The fund investment size can reach up to EUR 20 million. The fund's investment team works closely with the Erasmus MC technology transfer office which facilitates the transfer to the private sector of developing technologies. The close cooperation also provides emerging technology firms and university researchers with seed funding opportunities with other venture capitalists, and focused financial and technical support. Investments have been made in the development of biochips for acute myeloid leukemia, brain tumors and myeloma, diagnostic and therapeutic tools for the treatment of vulnerable plaques, medical diagnostic instruments in the field of micro-organism identification and skin composition analysis, and new drug targets for a wide array of bone diseases, including osteoporosis, osteoarthritis, and bone metastasis.	Founder	01/01/2016
Seed Fund Management BV Seed Fund Management BV Investment ManagersFinance Functions as an alternative investment manager	Founder	01/01/2016
Twente Technology Fund Management BV Twente Technology Fund Management BV Investment ManagersFinance Acts as an alternative investment manager	Private Equity Investor	01/01/2016
AIMM Therapeutics BV AIMM Therapeutics BV Pharmaceuticals: MajorHealth Technology Develops therapeutic antibodies for the treatment of cancer and infectious diseases	Chairman	-
Micronit Microfluidics BV Micronit Microfluidics BV SemiconductorsElectronic Technology Designs, develops, and manufactures glass-based lab-on-a-chip products	Director/Board Member	-

See the detail of Tom Schwarz's experience

Training of Tom Schwarz

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Tom Schwarz's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	11
LSP Management Group BV LSP Management Group BV Investment ManagersFinance EQT Life Sciences invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, medical devices, diagnostics and healthtech sectors. It provides financing for early and later stage capital requirements with an investment size of EUR 10 – 60 million.	Finance
University of Utrecht University of Utrecht Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Corgo NV Corgo NV Miscellaneous Commercial ServicesCommercial Services Specializes in corporate consulting services	Commercial Services
Erasmus Medical Center (Private Equity) Erasmus Medical Center (Private Equity) Investment ManagersFinance The Erasmus Fund's investment objective is to provide capital to support biomedical entrepreneurial activity at the Erasmus MC as well as in the Rotterdam area. The fund's investment strategy targets pre-seed, seed and early-stage firms and university spin-outs that are developing commercially promising technologies and products. They focus on the life science sector, including biotechnology, biomedical, pharmaceuticals, information technology and other high technology opportunities. The fund investment size can reach up to EUR 20 million. The fund's investment team works closely with the Erasmus MC technology transfer office which facilitates the transfer to the private sector of developing technologies. The close cooperation also provides emerging technology firms and university researchers with seed funding opportunities with other venture capitalists, and focused financial and technical support. Investments have been made in the development of biochips for acute myeloid leukemia, brain tumors and myeloma, diagnostic and therapeutic tools for the treatment of vulnerable plaques, medical diagnostic instruments in the field of micro-organism identification and skin composition analysis, and new drug targets for a wide array of bone diseases, including osteoporosis, osteoarthritis, and bone metastasis.	Finance
Micronit Microfluidics BV Micronit Microfluidics BV SemiconductorsElectronic Technology Designs, develops, and manufactures glass-based lab-on-a-chip products	Electronic Technology
Twente Technology Fund Management BV Twente Technology Fund Management BV Investment ManagersFinance Acts as an alternative investment manager	Finance
Regenesance BV Regenesance BV Drugstore ChainsRetail Trade Develops drugs for the treatment of neurodegenerative and immune mediated disorders	Retail Trade
Seed Fund Management BV Seed Fund Management BV Investment ManagersFinance Functions as an alternative investment manager	Finance
AIMM Therapeutics BV AIMM Therapeutics BV Pharmaceuticals: MajorHealth Technology Develops therapeutic antibodies for the treatment of cancer and infectious diseases	Health Technology
20Med Therapeutics BV 20Med Therapeutics BV BiotechnologyHealth Technology Operates as a biomedical company	Health Technology
Innovation Industries Management BV Innovation Industries Management BV Investment ManagersFinance Innovation Industries Management invests in companies located in Netherlands. The firm targets companies operating in the fields of industrial tech, med-tech and agri-tech industries. It provides for early and growth stage capital requirements with an investment size up to EUR 150 million.	Finance